David Tompkins

Has grant

Director, Division of Substance Abuse and Addiction Medicine / Associate Clinical Professor

UCSF School of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

The Effect of Chronic Pain on Delay Discounting in Methadone Patients

Open Date: 2019-09-30

Close Date: 2021-08-31

Grant: Close

Optimizing Pain Treatment while Reducing Abuse Liability in Opioid Dependence

Open Date: 2012-07-01

Close Date: 2017-05-31

Articles (8)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Jack Drescher

Clinical Professor

Columbia University

UNITED STATES

View details

Elise Weerts

Professor

Johns Hopkins University School of Medicine

UNITED STATES

View details

Meredith Meacham

University of California, San Francisco

UNITED STATES

View details

Valerie Gruber

Clinical Professor

University of California, San Francisco

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David Tompkins

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (8)

Substance Use in the Performing Artist with Chronic Pain.

"I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums.

Assessing the Acceptability of Yoga Among Patients with and without Chronic Pain Enrolled in a Licensed Opioid Treatment Program.

A Qualitative Investigation Into Faith and LGBTQ Identities in a Nonclinical Sample of Readers of the Dear Abby Column: The Dear Abby Project.

National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status.

Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.

Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemic.

Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes

Collaborators (4)

Jack Drescher

Elise Weerts

Meredith Meacham

Valerie Gruber

Make your next move.